文献速递胃肠外科

胃前哨淋巴结定位的临床前评估:甘露糖标记磁性纳米颗粒与吲哚菁绿

Preclinical evaluation of sentinel node localization in the stomach via mannose-labelled magnetic nanoparticles and indocyanine green.
PubMed 文献 · Surg Endosc · 2023-05-10

研究在8头健康猪中腹腔镜注射甘露糖标记磁性示踪剂FerroTrace和荧光染料吲哚菁绿(ICG),评估胃前哨淋巴结(SLN)定位可行性。结果示踪剂混合确保荧光与磁信号一致,MRI和磁强计检测SLN灵敏度100%,FerroTrace对SLN特异性高。双示踪剂法可术前MRI识别、术中荧光可视、磁强计确认SLN。

要点

  • 双示踪剂(ICG+FerroTrace)可实现胃SLN术前MRI、术中荧光和磁强计多模态定位。
  • FerroTrace对SLN特异性高,含76±30%淋巴趋铁和88±20%磁信号。
  • MRI和磁强计检测SLN灵敏度达100%,但样本量小(n=7)。

核心结论

  • 双示踪剂法结合ICG敏感性和FerroTrace的SLN特异性,可用于胃癌可靠SLN检测。

研究设计与样本

  • 在8头健康猪全麻下腹腔镜胃黏膜下注射FerroTrace和ICG,行机器人(n=2)或开腹(n=6)淋巴结清扫。

主要发现

  • ICG与FerroTrace混合确保SLN中荧光和磁信号一致。
  • 机器人清扫移除所有磁性淋巴结(n=4)。
  • 开腹靶向ICG-LN清扫平均每只动物移除4.7±1.2枚荧光淋巴结和2.0±1.3枚磁性淋巴结。
  • MRI和磁强计检测SLN灵敏度均为100%(n=7)。
  • FerroTrace高特异性:SLN含76±30%总淋巴趋铁和88±20%总磁强计信号。

临床怎么用

  • 该双示踪剂法有望用于胃癌SLN导航,可能减少不必要淋巴结清扫,并潜在应用于新辅助治疗。

局限性

  • 临床前动物研究,样本量小(8头猪),需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastrectomy with extended (D2) lymphadenectomy is considered standard of care for gastric cancer to provide the best possible outcomes and pathologic staging. However, D2 gastrectomy is a technically demanding operation and reported to be associated with increased complications and mortality. Application of sentinel lymph node (SLN) concept in gastric cancer has the potential to reduce patient morbidity; however, SLN techniques are not established for gastrectomy, in part due to lack of practical tracers. An effective and convenient tracer with enhanced SLN accumulation is critically needed. METHODS: Mannose-labelled magnetic tracer 'FerroTrace' and fluorescent dye indocyanine green (ICG) were injected laparoscopically into the stomach submucosa of 8 healthy swine under general anaesthesia. Intraoperative fluorescence imaging was used to highlight draining lymphatic pathways containing ICG, while preoperative T2-weighted MRI and ex vivo magnetometer probe measurements were used to identify nodes containing FerroTrace. Lymphadenectomy was performed either robotically (n = 2) or via laparotomy (n = 6). RESULTS: Mixing ICG and FerroTrace ensured concurrence of fluorescent and magnetic signals in SLNs. An initial trial with robotic dissection removed all magnetic LNs (n = 4). In the subsequent laparotomy study that targeted all ICG-LNs based on intraoperative fluorescence imaging, dissection removed an average of 4.7 ± 1.2 fluorescent, and 2.0 ± 1.3 magnetic LNs per animal. Both MRI and magnetometer detected 100% of SLNs (n = 7). FerroTrace demonstrated high specificity to SLNs, which contained 76 ± 30% of total lymphotropic iron, and 88 ± 20 % of the overall magnetometer signal. CONCLUSIONS: Through utilisation of this dual tracer approach, SLNs were identified via preoperative MRI, visualised intraoperatively with fluorescence imaging, and confirmed with a magnetometer. This combination pairs the sensitivity of ICG with SLN-specific FerroTrace and can be used for reliable SLN detection in gastric cancer, with potential applications in neoadjuvant therapy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Cousins A, Krishnan S, Krishnan G, et al. Preclinical evaluation of sentinel node localization in the stomach via mannose-labelled magnetic nanoparticles and indocyanine green. Surg Endosc. 2023. PMID: 37165173. doi:10.1007/s00464-023-10099-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。